A PYMNTS Company

China: Vitamin C dispute clashes over U.S. Antitrust Law

By  |  January 29, 2015

A price-fixing fight over a common dietary supplement made mostly by companies in China has set the stage for a US appeals court to consider differences between American competition law and the Chinese government.

Hebei Welcome Pharmaceutical Co. and its state-owned parent, North China Pharmaceutical Group Corp., were required by law to coordinate export prices and volumes, the ministry said in a filing to the US Court of Appeals in Manhattan, which is scheduled to hear the Chinese companies’ request to throw out the verdict on Thursday.

North China Pharmaceutical Group, a leading Chinese drug maker, said it shouldn’t even be implicated in the case because it had no contact with U.S. vitamin C buyers and didn’t exert day-to-day control over Hebei Welcome. Both companies are based in Shijiazhuang, China

Full Content: Bloomberg

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.